AllergoOncology: Anti-EGFR IgE triggers potent tumor cell killing by mast cells and monocytes (2018)
Attributed to:
Preclinical efficacy of an antibody of the IgE class against a melanoma-associated antigen
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Type: Conference/Paper/Proceeding/Abstract
Volume: 73
Parent Publication: ALLERGY
ISSN: 0105-4538